Normal human microbiota
- Basics
The microbes that normally live on the skin and in the mouth, gut and vagina: mostly useful and protective, and a source of infection out of place.
What it is
The normal microbiota (or microbiome) is the community of bacteria, fungi and viruses that lives on body surfaces without causing disease. It trains the immune system, helps digestion and vitamin production, and occupies space and nutrients that a pathogen would otherwise use, which is called colonisation resistance. Composition differs sharply by site and person, while the metabolic functions the community performs are much more similar between people. Normal residents become pathogens when barriers break, when devices are inserted, when immunity falls, or when antibiotics clear their competitors.
Key facts
- The Human Microbiome Project sampled healthy adults at many body sites and found that each person's community is distinctive and fairly stable over time, while the metabolic pathways present are far more uniform than the species carrying them
- Colonisation resistance: resident microbes compete for space and nutrients and produce inhibitory substances, so clearing them with antibiotics opens the way for Clostridioides difficile and Candida
- Dysbiosis, a shift in the community, is associated with antibiotic-associated diarrhoea, bacterial vaginosis and inflammatory bowel disease, and causation is still being worked out
- Newborn colonisation begins at birth and is shaped by delivery route, feeding and antibiotics; breast milk favours bifidobacteria
- Germ-free animals show that the microbiota is needed for normal gut immune development and for vitamin K and some B vitamins
- Probiotics are live microorganisms taken to influence this community; evidence is strongest for preventing antibiotic-associated diarrhoea, and they carry real risk in severely ill or very premature patients
- Faecal microbiota transplantation (screened donor stool) is the clearest proof that the community matters: in a randomised trial it resolved recurrent C. difficile infection in 81% against 31% with vancomycin; donor screening guards against passing on resistant organisms
- Lower microbial diversity is found again and again in inflammatory bowel disease, obesity, type 1 and type 2 diabetes, coeliac disease and atopic eczema, but these are associations that do not show which comes first
- Metabolic links: fibre-fermenting bacteria make short-chain fatty acids such as butyrate, the main fuel of colon cells, which also act on glucose control and gut hormones; germ-free mice given stool from obese people gain more weight
- Proven versus hypothesis: faecal transplant for recurrent C. difficile is established practice; for obesity, metabolic syndrome, inflammatory bowel disease and other conditions it is still experimental, and much causal evidence comes from mice
Step by step
- Resident flora occupy space and nutrients and make inhibitory substances: colonisation resistance
- A broad-spectrum antibiotic kills much of the protective gut flora
- Swallowed C. difficile spores now find room and nutrients to germinate
- The bacterium multiplies in the colon and its toxins cause C. difficile infection
- Risk is highest during the course and in the month after it, while the flora is still depleted
Who lives where
| Site | Usual residents | Notes |
|---|---|---|
| Skin | Coagulase-negative staphylococci (S. epidermidis), Corynebacterium, Cutibacterium acnes, Malassezia; S. aureus in the nose in part of the population | Source of catheter and prosthesis infection and of blood-culture contamination |
| Mouth and oropharynx | Viridans streptococci, Neisseria species, anaerobes (Prevotella, Fusobacterium, Veillonella), Actinomyces, Candida | Dental plaque is a biofilm; viridans streptococci reach damaged valves after dental procedures |
| Stomach and small bowel | Few organisms because of acid and rapid transit; Helicobacter pylori in colonised stomachs | Acid suppression allows more bacterial growth |
| Colon | Dominated by obligate anaerobes (Bacteroides, Clostridia, Bifidobacterium) with far fewer Enterobacterales and enterococci | Anaerobes outnumber aerobes by roughly a thousand to one; source of intra-abdominal and perianal infection |
| Vagina | Lactobacillus-dominated, with the simplest community in the body; lactic acid keeps the pH low | Loss of lactobacilli gives bacterial vaginosis; oestrogen status changes the community |
| Distal (anterior) urethra | Scanty skin and genital flora | Bladder urine is normally not sterile but has very low biomass |
| Conjunctiva | Sparse: coagulase-negative staphylococci, Corynebacterium | Tears with lysozyme and IgA keep numbers low |
| Normally sterile in health | Blood, cerebrospinal fluid, pleural, pericardial, synovial and peritoneal fluid, deep tissue, lower airway (very low biomass) | Growth from these sites is taken seriously |
Clinical notes
- Most endogenous infections are caused by the patient's own flora displaced to a sterile site: gut anaerobes after bowel perforation, skin flora on a catheter, oral streptococci on a damaged valve
- A blood culture growing coagulase-negative staphylococci from one bottle usually means skin contamination rather than bacteraemia
- Broad-spectrum antibiotics are the main modifiable cause of Clostridioides difficile infection; risk is highest during and in the month after the course
- Specimens from sites with their own flora (sputum, stool, vaginal swab, wound surface) must be interpreted against what normally lives there
In the lab
- Culture results are read in context: an organism from a normally sterile site is meaningful, the same organism from a colonised surface may not be
- Quantitative or semi-quantitative reporting helps with urine and respiratory samples
- Sequencing methods (16S ribosomal RNA genes and metagenomics) describe communities that culture misses
Common traps
- Any organism grown in a culture is causing infection: an organism from a colonised surface may be normal flora, while the same organism from blood or cerebrospinal fluid needs explanation.
- One blood culture bottle growing coagulase-negative staphylococci means bacteraemia: from a single bottle it usually means skin contamination.
- Most colonic bacteria are E. coli: obligate anaerobes outnumber facultative bacteria such as E. coli by roughly a thousand to one.
- Probiotics are harmless for everyone: they carry real risk in severely ill or very premature patients, and the evidence is strongest only for preventing antibiotic-associated diarrhoea.
- Low microbiome diversity in a disease proves the microbes cause it: most human data are associations, and findings in mice may not hold in people.
Test yourself
Think of the answer, then tap the question to see it.
Days after a perforated appendix, a patient has a pelvic abscess. Which organisms are expected, and where did they come from?
The patient's own colonic flora: mainly obligate anaerobes such as Bacteroides, with Enterobacterales and enterococci, moved from the bowel into a sterile space.
Ten days after a broad-spectrum antibiotic course, a patient has watery diarrhoea. Why is the timing typical of C. difficile infection?
The antibiotic cleared the protective gut flora and removed colonisation resistance; risk stays high during the course and for about a month after it.
A patient with bacterial vaginosis has a raised vaginal pH. Which change in the flora explains both?
Loss of Lactobacillus, whose lactic acid normally keeps the pH low, which lets a mixed anaerobic community overgrow.
A patient with a damaged heart valve develops endocarditis weeks after dental work. Which resident is the likely cause, and why?
Viridans streptococci from the mouth: they reach the blood during dental procedures and settle on damaged valves.
Why is Candida grown from a mouth swab usually unimportant, while Candida in a blood culture is always significant?
Candida is a normal mouth resident, so a swab shows colonisation; blood is normally free of microbes, so any growth there needs explanation.
Connections
Microorganisms13
In Pharmacology3
Educational content on microorganisms; not a treatment guide and no substitute for a health professional's advice. No doses are given.
Sources: Structure, Function and Diversity of the Healthy Human Microbiome (Nature (Human Microbiome Project Consortium), 2012); Microbiome (National Human Genome Research Institute (NHGRI), 2026); Probiotics: Usefulness and Safety (National Center for Complementary and Integrative Health (NIH), 2019); About C. diff | C. diff | CDC (Centers for Disease Control and Prevention (CDC), 2026); Role of the gut microbiota in nutrition and health (BMJ (Europe PMC), 2018); Fecal microbiota transplantation as a therapeutic modality for recurrent Clostridioides difficile infection: reviewing efficacy, safety, mechanisms of action, and outcomes (Annals of Medicine and Surgery (Europe PMC), 2025).
Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake
Representative model, for educational purposes only.
